Sign up for more information

Please complete the form to receive information from UCB about developments in mitochondrial disease and TK2d.

All fields are required unless marked as optional.


This website is neither intended nor designed to record or report adverse events. If you have adverse events to report for a UCB product, please follow the current regulatory procedure in your country or click on the following link to access the contact page of the UCB corporate website where you can report adverse events to UCB local affiliate contacts, UCBCares or by completing the UCB AE webform.


‎ ‎
GL-DA-2600210 | Date of preparation: May 2026
© UCB Biopharma SRL, 2026. All rights reserved.